ClinConnect ClinConnect Logo
Search / Trial NCT06074939

FRESHAIR4Life: Building the Case for Action

Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Oct 4, 2023

Trial Information

Current as of September 10, 2025

Not yet recruiting

Keywords

Implementation Studies Mixed Methods Participatory Research

ClinConnect Summary

The FRESHAIR4Life study is an important research project that aims to learn more about the impact of tobacco use and air pollution on young people, specifically those aged 14 to 21, in countries like Greece, Pakistan, and Uganda. The researchers want to understand how these issues affect adolescents and what factors contribute to these problems. They will gather information by talking to young people, their family members, teachers, and community leaders. This will help them figure out how to create better prevention programs in the future.

If you or someone you know is a mid- to late-adolescent between 14 and 21 years old, or if you are a family member or a community worker involved with young people, you may be eligible to participate in this study. Participants can expect to share their thoughts and experiences through interviews and discussions. The goal is to gather insights that will help improve health outcomes for young people facing challenges from tobacco use and pollution.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adolescents: mid- to late-adolescents (14 to 21 years) within the target population;
  • Family members: relatives in the first or second degree of (not necessarily participating) adolescents;
  • Providers: any relevant stakeholder that is connected to adolescents through profession (e.g. school teacher, youth worker) and/or providers of (public) healthcare;
  • Stakeholders: any relevant stakeholder with either a specific expertise, in-depth knowledge or overall overview on the subject, and in direct contact with the community (e.g. community member/leader, policy maker). Due to the community- and individual-level focus of this research, individuals associated with the tobacco industry are deliberately not included as stakeholders.
  • Exclusion Criteria:
  • - People living outside the target area or not in direct contact with the target population.

About Leiden University Medical Center

Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.

Locations

Patients applied

0 patients applied

Trial Officials

Rianne MJJ van der Kleij, PhD

Principal Investigator

Leiden University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported